News
September 12, 2017
Akcea and Ionis Announce Filing of New Drug Submission for Volanesorsen to Health CanadaSeptember 11, 2017
New Data Presented at European Society for Medical Oncology Meeting Demonstrate Antitumor Activity with IONIS-STAT3-2.5 Rx in Combination with Imfinzi
Spotlight
SPINRAZA: An Exemplary Development Path for Gene Therapies to Follow
More »
Newly Published Preclinical Data Demonstrate the Potential of IONIS-KRAS-2.5Rx in Cancer
More »
Nature Communications Publishes Preclinical Results Evaluating Antisense Drugs Targeting DNM2 for the Treatment of Centronuclear Myopathy
More »
Newly Published Data Characterizes the Burden of Disease in Patients with Familial Chylomicronemia Syndrome
More »
Clinical Trials
We have numerous ongoing clinical trials designed to evaluate our drugs in a variety of health conditions. More »
Events
No upcoming events at this time...